Medtronic received information that prior to use, this act plus instrument had an unreliable reading of the test piece.The use of the instrument was unspecified.There was no patient involvement, so no adverse effect occurred.Medtronic received additional information that the instrument failed liquid and electronic quality control.The customer stated that there were inaccurate measurement results.
|
Device evaluation:the reported unreliable reading of the test piece was verified during service.The issue was resolved by calibrating the instrument parameters, testing the instrument, the electrical safety was checked, and the instrument passed all tests.Post repair testing was performed per specifications.Note:instrument was not returned to medtronic facility but was serviced by field service technician.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|